Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002397150 | SCV002702545 | pathogenic | Hereditary cancer-predisposing syndrome | 2017-07-27 | criteria provided, single submitter | clinical testing | The p.S494* pathogenic mutation (also known as c.1481C>A), located in coding exon 9 of the MSH2 gene, results from a C to A substitution at nucleotide position 1481. This changes the amino acid from a serine to a stop codon within coding exon 9. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |